Comparator Drug Sourcing Market to Expand at 3.5% CAGR from 2023 to 2031|Growth Market Reports
Latest Developments:
In January 2023, Avantor, Inc (NYSE: AVTR) one of the leading companies in the market announced a multi-year supply and services agreement with Catalent, Inc. (NYSE: CTLT). Catalent is a major global firm that works on developing and supplying solutions that enable providing patients with better treatments worldwide. As per the agreement, Avantor is to be the primary provider of various laboratory supplies, production and clinical materials, and services to Catalent.
Key Market Players Profiled in the Report
- AmerisourceBergen Corporation
- Avantor, Inc.
- Clinical Services International (CSI)
- Clinigen Clinical Supplies Management
- Intertek Group plc
- MCKESSON CORPORATION
- Myonex
- PHARMA'S ALMANAC
- Sharp Services, LLC
- Thermo Fisher Scientific
- TransCelerate BioPharma Inc.
Download PDF Sample here: https://growthmarketreports.com/request-sample/5063
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the industry's market dynamics. It provides an in-depth analysis of the market segments, including end-user and competitor analysis.
This report also includes a complete analysis of industry players and covers their latest developments, product portfolio, pricing, mergers, acquisitions, and collaborations. Moreover, it provides crucial strategies that are helping market players to expand their market share.
For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/5063
Highlights on the Segments of the Comparator Drug Sourcing Market
On the basis of region, the global comparator drug sourcing market is divided into
To Buy the Complete Report: https://growthmarketreports.com/report/comparator-drug-sourcing-market-global-industry-analysis
Key Takeaways from the Study:
- Comparator drug sourcing refers to the procurement of existing drugs for comparing them with newly developed drugs during clinical trials. In the process, instead of comparing the new drug with placebo medications in the trial, its compatibility is actually tested against the similar available drugs in the market.
- The investment in comparator drugs sourcing is growing by pharmaceutical firms, as there is a need to justify new drugs effectivity and costs against the existing drugs.
- For a pharma company to claim its drug's superiority in treating certain diseases, the trial requires the inclusion of an active comparator drug. The drug manufacturer is required to select comparator drugs against their new drug, and source and supply to every trial site in an uninterrupted manner.
- The increasing need to justify the effectiveness and price of newly developed drugs to the stakeholders such as insurance companies, government regulators, and pharmacies is driving the need for comparator drug sourcing across global pharmaceutical research and development establishments.
- The increasing prevalence of chronic disease diseases including cancer, cardiac, and neurological disorders is driving the development of new drugs, which is fueling the market of comparator drug sourcing, for comparative analysis.
- The development of drugs against bacterial infection is likely to create opportunities for the market. The COVID-19 pandemic propelled the need for developing effective drugs against various bacterial infections, which has opened opportunities to develop superior drugs.
- Based on the end-user segment, the market is categorized into drug producers/manufacturers, CMO, academic, and research institutes. Of which, the drug producers/manufacturers segment held a significant share of the market in 2022, and is likely to expand at a rapid CAGR during the forecast period.
Read 164 Pages Research Report with Detailed TOC on "Comparator Drug Sourcing Market by End-user (Drug Producers/Manufacturers, CMO, Academic, and Research Institute), and Region (
Get Full Access to this Report: https://growthmarketreports.com/checkout/5063
Key Segments Covered
End-user
- Drug Producers/Manufacturers
- CMO
- Academic and Research Institute
- Others
Region
North America Europe Asia Pacific Latin America Middle East &Africa
Other Related Reports:
- Pharmaceutical Manufacturing Market Segments - by Drug Development Types (Outsource and In-house), Formulations (Tablets, Capsules, Suspensions, Injectable, Powders, Sprays, and Others), Routes of Administration (Oral, Parenteral, Topical, Inhalations, and Others), Therapy Areas (Cardiovascular Diseases, Diabetes, Pain, Respiratory Diseases, Cancer, and Others), Prescriptions (Prescription Medicines and Over-the-counter Medicines), Age Groups (Children & Adolescents, Adults, and Geriatric), Distribution Channels (Retail and Non-retail), and Regions (
Asia Pacific ,North America ,Latin America ,Europe , andMiddle East &Africa ) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028. - Global Clinical Trial Supply and Logistics for Pharmaceutical Market by Type (Clinical Trial Packaging Services, Clinical Trial Cold Chain Logistics, Others), By Application (Clinical Trial Manufacturing, Clinical Trial Logistics, and Distributions, Clinical Trial Supply Chain Management), And By Region (
North America ,Latin America ,Europe ,Asia Pacific , andMiddle East &Africa ), Forecast From 2022 To 2030 - Global Clinical Trials Consumables Market by Type (Plastic Labware, Lab Glassware, Others), By Application (Biopharmaceutical, Medical, Others) and Region (
North America ,Latin America ,Europe ,Asia Pacific andMiddle East &Africa ), Forecast To 2028 - Global Generic Drugs Market by Type (Simple Generic Drugs, Super Generic Drugs, Biosimilars), By Application (CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology, Others), And By Region (
North America ,Latin America ,Europe ,Asia Pacific , andMiddle East &Africa ), Forecast From 2022 To 2030
About Growth Market Reports:
Growth Market Reports provides global enterprises as well as small & medium businesses with unmatched quality of "Market Research Reports" and "Industry Intelligence Solutions". Growth Market Reports has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.
Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, and secondary research & consumer surveys.
Contact:
Alex Mathews
7th Floor, Siddh Icon,
Baner Road, Pune.
Phone: +1 909 414 1393
Email: sales@growthmarketreports.com
Web: https://growthmarketreports.com/
Twitter: https://twitter.com/growth_reports
LinkedIn: https://www.linkedin.com/company/growth-market-report/
Logo: https://mma.prnewswire.com/media/1980656/Growth_Market_Reports_Logo1.jpg
View original content:https://www.prnewswire.com/news-releases/comparator-drug-sourcing-market-to-expand-at-3-5-cagr-from-2023-to-2031growth-market-reports-301830955.html
SOURCE Growth Market Reports
